Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma

Ken Takahashi, Masao Miyashita, Hiroshi Makino, Ichiro Akagi, Hajime Orita, Nobutoshi Hagiwara, Tsutomu Nomura, Edward Gabrielson, Takashi Tajiri

Research output: Contribution to journalArticle

Abstract

The Akt-Mdm2 pathway plays an important role in carcinogenesis in a variety of malignant tumors. However, the Akt-Mdm2 pathway in esophageal squamous cell carcinoma (ESCC) has not been fully studied. We investigated the proteins and mRNA expression of Akt and Mdm2 to elucidate the roles of these proteins in ESCC. We also examined the effect of Akt knockdown on Mdm2 expression in ESCC cells. ESCC tissue samples were obtained from 23 individuals who underwent surgical resection with no preoperative treatment. Akt1-3 and Mdm2 gene and protein expression were analyzed. The effect of siRNA-mediated Akt knockdown on Mdm2 expression was also studied, using ESCC cell lines. Akt1 and Mdm2 immunoreactivity was detected in 77.8 and 66.7% of tumor specimen from ESCC patients, respectively. Akt1 and Mdm2 mRNA expressions were correlated and significantly elevated in tumor tissue (p <0.0001 and p <0.05, respectively). The siRNA-targeted reduction of each Akt isoform reduced Mdm2 protein expression. The overexpression of Akt1 and Mdm2 may be related to esophageal carcinogenesis. Furthermore, Akt expression regulates Mdm2 expression, which may in turn regulate the function of wild-type p53. These results may provide the basis for future preventative or clinical therapies for esophageal cancer.

Original languageEnglish (US)
Pages (from-to)42-47
Number of pages6
JournalExperimental and Molecular Pathology
Volume87
Issue number1
DOIs
StatePublished - Aug 2009

Fingerprint

Proto-Oncogene Proteins c-mdm2
Tumors
Small Interfering RNA
Carcinogenesis
Tissue
Neoplasms
Messenger RNA
Proteins
Esophageal Neoplasms
Esophageal Squamous Cell Carcinoma
Epithelial Cells
Protein Isoforms
Cells
Gene Expression
Cell Line
Therapeutics

Keywords

  • Akt1
  • Akt2
  • Akt3
  • Esophageal carcinoma
  • Mdm2
  • siRNA

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Takahashi, K., Miyashita, M., Makino, H., Akagi, I., Orita, H., Hagiwara, N., ... Tajiri, T. (2009). Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. Experimental and Molecular Pathology, 87(1), 42-47. https://doi.org/10.1016/j.yexmp.2008.11.013

Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. / Takahashi, Ken; Miyashita, Masao; Makino, Hiroshi; Akagi, Ichiro; Orita, Hajime; Hagiwara, Nobutoshi; Nomura, Tsutomu; Gabrielson, Edward; Tajiri, Takashi.

In: Experimental and Molecular Pathology, Vol. 87, No. 1, 08.2009, p. 42-47.

Research output: Contribution to journalArticle

Takahashi, K, Miyashita, M, Makino, H, Akagi, I, Orita, H, Hagiwara, N, Nomura, T, Gabrielson, E & Tajiri, T 2009, 'Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma', Experimental and Molecular Pathology, vol. 87, no. 1, pp. 42-47. https://doi.org/10.1016/j.yexmp.2008.11.013
Takahashi, Ken ; Miyashita, Masao ; Makino, Hiroshi ; Akagi, Ichiro ; Orita, Hajime ; Hagiwara, Nobutoshi ; Nomura, Tsutomu ; Gabrielson, Edward ; Tajiri, Takashi. / Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma. In: Experimental and Molecular Pathology. 2009 ; Vol. 87, No. 1. pp. 42-47.
@article{0f08307da194496ca0b2410a0ead5a44,
title = "Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma",
abstract = "The Akt-Mdm2 pathway plays an important role in carcinogenesis in a variety of malignant tumors. However, the Akt-Mdm2 pathway in esophageal squamous cell carcinoma (ESCC) has not been fully studied. We investigated the proteins and mRNA expression of Akt and Mdm2 to elucidate the roles of these proteins in ESCC. We also examined the effect of Akt knockdown on Mdm2 expression in ESCC cells. ESCC tissue samples were obtained from 23 individuals who underwent surgical resection with no preoperative treatment. Akt1-3 and Mdm2 gene and protein expression were analyzed. The effect of siRNA-mediated Akt knockdown on Mdm2 expression was also studied, using ESCC cell lines. Akt1 and Mdm2 immunoreactivity was detected in 77.8 and 66.7{\%} of tumor specimen from ESCC patients, respectively. Akt1 and Mdm2 mRNA expressions were correlated and significantly elevated in tumor tissue (p <0.0001 and p <0.05, respectively). The siRNA-targeted reduction of each Akt isoform reduced Mdm2 protein expression. The overexpression of Akt1 and Mdm2 may be related to esophageal carcinogenesis. Furthermore, Akt expression regulates Mdm2 expression, which may in turn regulate the function of wild-type p53. These results may provide the basis for future preventative or clinical therapies for esophageal cancer.",
keywords = "Akt1, Akt2, Akt3, Esophageal carcinoma, Mdm2, siRNA",
author = "Ken Takahashi and Masao Miyashita and Hiroshi Makino and Ichiro Akagi and Hajime Orita and Nobutoshi Hagiwara and Tsutomu Nomura and Edward Gabrielson and Takashi Tajiri",
year = "2009",
month = "8",
doi = "10.1016/j.yexmp.2008.11.013",
language = "English (US)",
volume = "87",
pages = "42--47",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Expression of Akt and Mdm2 in human esophageal squamous cell carcinoma

AU - Takahashi, Ken

AU - Miyashita, Masao

AU - Makino, Hiroshi

AU - Akagi, Ichiro

AU - Orita, Hajime

AU - Hagiwara, Nobutoshi

AU - Nomura, Tsutomu

AU - Gabrielson, Edward

AU - Tajiri, Takashi

PY - 2009/8

Y1 - 2009/8

N2 - The Akt-Mdm2 pathway plays an important role in carcinogenesis in a variety of malignant tumors. However, the Akt-Mdm2 pathway in esophageal squamous cell carcinoma (ESCC) has not been fully studied. We investigated the proteins and mRNA expression of Akt and Mdm2 to elucidate the roles of these proteins in ESCC. We also examined the effect of Akt knockdown on Mdm2 expression in ESCC cells. ESCC tissue samples were obtained from 23 individuals who underwent surgical resection with no preoperative treatment. Akt1-3 and Mdm2 gene and protein expression were analyzed. The effect of siRNA-mediated Akt knockdown on Mdm2 expression was also studied, using ESCC cell lines. Akt1 and Mdm2 immunoreactivity was detected in 77.8 and 66.7% of tumor specimen from ESCC patients, respectively. Akt1 and Mdm2 mRNA expressions were correlated and significantly elevated in tumor tissue (p <0.0001 and p <0.05, respectively). The siRNA-targeted reduction of each Akt isoform reduced Mdm2 protein expression. The overexpression of Akt1 and Mdm2 may be related to esophageal carcinogenesis. Furthermore, Akt expression regulates Mdm2 expression, which may in turn regulate the function of wild-type p53. These results may provide the basis for future preventative or clinical therapies for esophageal cancer.

AB - The Akt-Mdm2 pathway plays an important role in carcinogenesis in a variety of malignant tumors. However, the Akt-Mdm2 pathway in esophageal squamous cell carcinoma (ESCC) has not been fully studied. We investigated the proteins and mRNA expression of Akt and Mdm2 to elucidate the roles of these proteins in ESCC. We also examined the effect of Akt knockdown on Mdm2 expression in ESCC cells. ESCC tissue samples were obtained from 23 individuals who underwent surgical resection with no preoperative treatment. Akt1-3 and Mdm2 gene and protein expression were analyzed. The effect of siRNA-mediated Akt knockdown on Mdm2 expression was also studied, using ESCC cell lines. Akt1 and Mdm2 immunoreactivity was detected in 77.8 and 66.7% of tumor specimen from ESCC patients, respectively. Akt1 and Mdm2 mRNA expressions were correlated and significantly elevated in tumor tissue (p <0.0001 and p <0.05, respectively). The siRNA-targeted reduction of each Akt isoform reduced Mdm2 protein expression. The overexpression of Akt1 and Mdm2 may be related to esophageal carcinogenesis. Furthermore, Akt expression regulates Mdm2 expression, which may in turn regulate the function of wild-type p53. These results may provide the basis for future preventative or clinical therapies for esophageal cancer.

KW - Akt1

KW - Akt2

KW - Akt3

KW - Esophageal carcinoma

KW - Mdm2

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=67649442836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649442836&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2008.11.013

DO - 10.1016/j.yexmp.2008.11.013

M3 - Article

C2 - 19124015

AN - SCOPUS:67649442836

VL - 87

SP - 42

EP - 47

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -